Anette Mullertz
Anette Mullertz
Bioneer:FARMA, Department of Pharmacy, University of Copenhagen
Email verificata su sund.ku.dk
Titolo
Citata da
Citata da
Anno
A dynamic in vitro lipolysis model: I. Controlling the rate of lipolysis by continuous addition of calcium
NH Zangenberg, A Müllertz, HG Kristensen, L Hovgaard
European Journal of Pharmaceutical Sciences 14 (2), 115-122, 2001
3292001
In vitro models for the prediction of in vivo performance of oral dosage forms
ES Kostewicz, B Abrahamsson, M Brewster, J Brouwers, J Butler, ...
European Journal of Pharmaceutical Sciences 57, 342-366, 2014
3072014
New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs
A Müllertz, A Ogbonna, S Ren, T Rades
Journal of pharmacy and pharmacology 62 (11), 1622-1636, 2010
2662010
Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories
R Hayeshi, C Hilgendorf, P Artursson, P Augustijns, B Brodin, ...
European Journal of Pharmaceutical Sciences 35 (5), 383-396, 2008
2572008
Lipid-based formulations for oral administration of poorly water-soluble drugs
H Mu, R Holm, A Müllertz
International journal of pharmaceutics 453 (1), 215-224, 2013
2492013
A dynamic in vitro lipolysis model: II: Evaluation of the model
NH Zangenberg, A Müllertz, HG Kristensen, L Hovgaard
European Journal of Pharmaceutical Sciences 14 (3), 237-244, 2001
2392001
Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs
CAS Bergström, R Holm, SA Jørgensen, SBE Andersson, P Artursson, ...
European Journal of Pharmaceutical Sciences 57, 173-199, 2014
2282014
Toward the establishment of standardized in vitro tests for lipid-based formulations, part 1: method parameterization and comparison of in vitro digestion profiles across a …
HD Williams, P Sassene, K Kleberg, JC Bakala-N'Goma, M Calderone, ...
Journal of pharmaceutical sciences 101 (9), 3360-3380, 2012
2182012
Solubilisation of poorly water-soluble drugs during in vitro lipolysis of medium-and long-chain triacylglycerols
JØ Christensen, K Schultz, B Mollgaard, HG Kristensen, A Mullertz
European Journal of Pharmaceutical Sciences 23 (3), 287-296, 2004
2132004
Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems …
R Holm, CJH Porter, GA Edwards, A Müllertz, HG Kristensen, ...
European Journal of Pharmaceutical Sciences 20 (1), 91-97, 2003
1882003
In vivo in vitro correlations for a poorly soluble drug, danazol, using the flow-through dissolution method with biorelevant dissolution media
VH Sunesen, BL Pedersen, HG Kristensen, A Müllertz
European journal of pharmaceutical sciences 24 (4), 305-313, 2005
1852005
In vitro and in vivo performance of novel supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS)
N Thomas, R Holm, A Müllertz, T Rades
Journal of controlled release 160 (1), 25-32, 2012
1792012
Bile salts and their importance for drug absorption
R Holm, A Müllertz, H Mu
International Journal of Pharmaceutics 453 (1), 44-55, 2013
1692013
Bioavailability of probucol from lipid and surfactant based formulations in minipigs: influence of droplet size and dietary state
FS Nielsen, KB Petersen, A Müllertz
European Journal of Pharmaceutics and Biopharmaceutics 69 (2), 553-562, 2008
1672008
Bioavailability of seocalcitol: II: development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long …
M Grove, A Müllertz, JL Nielsen, GP Pedersen
European journal of pharmaceutical sciences 28 (3), 233-242, 2006
1542006
A comparison of the solubility of danazol in human and simulated gastrointestinal fluids
BL Pedersen, A Mullertz, H Brondsted, HG Kristensen
Pharmaceutical research 17 (7), 891, 2000
1522000
In vitro lipolysis models as a tool for the characterization of oral lipid and surfactant based drug delivery systems
AT Larsen, P Sassene, A Müllertz
International journal of pharmaceutics 417 (1-2), 245-255, 2011
1452011
Clinical studies with oral lipid based formulations of poorly soluble compounds
DG Fatouros, DM Karpf, FS Nielsen, A Mullertz
Therapeutics and clinical risk management 3 (4), 591, 2007
1422007
Morphological observations on a lipid-based drug delivery system during in vitro digestion
DG Fatouros, B Bergenstahl, A Mullertz
European journal of pharmaceutical sciences 31 (2), 85-94, 2007
1422007
Enzyme supplementation of wheat-based diets for broilers: 1. Effect on growth performance and intestinal viscosity
S Steenfeldt, A Müllertz, JF Jensen
Animal Feed Science and Technology 75 (1), 27-43, 1998
1331998
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20